SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K et al (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human p301s tau protein. J Neurosci 22:93409351.
  • 2
    Borchelt DR, Davis J, Fischer M, Lee MK, Slunt HH, Ratovitsky T et al (1996) A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 13:159163.
  • 3
    Bugiani O, Giaccone G, Verga L, Pollo B, Frangione B, Farlow MR et al (1993) Beta PP participates in PrP-amyloid plaques of Gerstmann-Sträussler-Scheinker disease, Indiana kindred. J Neuropathol Exp Neurol 52:6470.
  • 4
    Choi SI, Vidal R, Frangione B, Levy E (2004) Axonal transport of British and Danish amyloid peptides via secretory vesicles. FASEB J 18:373375.
  • 5
    Christie R, Yamada M, Moskowitz M, Hyman B (2001) Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am J Pathol 158:10651071.
  • 6
    Coomaraswamy J, Herzig MC, Kaeser SA, Ghiso J, Jucker M (2006) Transgenic mouse models of familial British and Danish dementias. Alzheimer's & Dementia 2:S116.
  • 7
    Deleersnijder W, Hong G, Cortvrindt R, Poirier C, Tylzanowski P, Pittois K et al (1996) Isolation of markers for chondro-osteogenic differentiation using cDNA library subtraction. Molecular cloning and characterization of a gene belonging to a novel multigene family of integral membrane proteins. J Biol Chem 271:1947519482.
  • 8
    Domnitz SB, Robbins EM, Hoang AW, Garcia-Alloza M, Hyman BT, Rebeck GW et al (2005) Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. J Neuropathol Exp Neurol 64:588594.
  • 9
    Eriksen JL, Janus CG (2007) Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav Genet 37:79100.
  • 10
    Gibson G, Gunasekera N, Lee M, Lelyveld V, El-Agnaf OM, Wright A, Austen B (2004) Oligomerization and neurotoxicity of the amyloid ADan peptide implicated in familial Danish dementia. J Neurochem 88:281290.
  • 11
    Gordon MN, Holcomb LA, Jantzen PT, DiCarlo G, Wilcock D, Boyett KW et al (2002) Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1 + APP mouse. Exp Neurol 173:183195.
  • 12
    Harkness KA, Coles A, Pohl U, Xuereb JH, Baron JC, Lennox GG (2004) Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy. Eur J Neurol 11:5962.
  • 13
    Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD et al (2004) Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7:954960.
  • 14
    Holton JL, Ghiso J, Lashley T, Rostagno A, Guerin CJ, Gibb G et al (2001) Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 158:515526.
  • 15
    Holton JL, Lashley T, Ghiso J, Braendgaard H, Vidal R, Guerin CJ et al (2002) Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol 61:254267.
  • 16
    Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486489.
  • 17
    Kim SH, Wang R, Gordon DJ, Bass J, Steiner DF, Lynn DG et al (1999) Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia. Nat Neurosci 2:984988.
  • 18
    Kim SH, Creemers JW, Chu S, Thinakaran G, Sisodia SS (2002) Proteolytic processing of familial British dementia-associated BRI variants: evidence for enhanced intracellular accumulation of amyloidogenic peptides. J Biol Chem 277:18721877.
  • 19
    Martin L, Fluhrer R, Reiss K, Kremmer E, Saftig P, Haass C (2008) Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/b. J Biol Chem 283:16441652.
  • 20
    McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C et al (2005) Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47:191199.
  • 21
    Miao J, Vitek MP, Xu F, Previti ML, Davis J, Van Nostrand WE (2005) Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice. J Neurosci 25:62716277.
  • 22
    Miao J, Xu F, Davis J, Otte-Höller I, Verbeek MM, Van Nostrand WE (2005) Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 167:505515.
  • 23
    Morgan D, Gordon MN, Tan J, Wilcock D, Rojiani AM (2005) Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J Neuropathol Exp Neurol 64:743753.
  • 24
    Nakayama K (1997) Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327:625635.
  • 25
    Oh U, Gupta R, Krakauer JW, Khandji AG, Chin SS, Elkind MS (2004) Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology 62:494947.
  • 26
    Plant GT, Esiri MM (1977) Familial cerebral amyloid angiopathies. In: The Neuropathology of Dementia. MMEsiri, JHMorris (eds), pp. 260276. University Press: Cambridge.
  • 27
    Rensink AA, De Waal RM, Kremer B, Verbeek MM (2003) Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev 43:207223.
  • 28
    Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A (2007) Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Int Rev Neurobiol 82:235246.
  • 29
    Rostagno A, Revesz T, Lashley T, Tomidokoro Y, Magnotti L, Braendgaard H et al (2002) Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease. J Biol Chem 277:4978249790.
  • 30
    Strömgren E (1981) Heredopathia ophthalmo-oto-encephalica. In: Handbook of Clinical Neurology. PJVinken, GWBruyn (eds), pp. 150152. North-Holland Publishing Company: Amsterdam.
  • 31
    Strömgren E, Dalby A, Dalby MA, Ranheim B (1970) Cataract, deafness, cerebellar ataxia, psychosis and dementia: a new syndrome. Acta Neurol Scand 46(Suppl. 43):261262.
  • 32
    Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den Haute C et al (2000) Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. Am J Pathol 157:12831298.
  • 33
    Vidal R, Frangione B, Rostagno A, Mead S, Révész T, Plant G, Ghiso J (1999) A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 399:776781.
  • 34
    Vidal R, Revesz T, Rostagno A, Kim E, Holton JL, Bek T et al (2000) A decamer duplication in the 3’ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci USA 97:49204925.
  • 35
    Vidal R, Delisle MB, Ghetti B (2004) Neurodegeneration caused by proteins with an aberrant carboxyl-terminus. J Neuropathol Exp Neurol 63:787800.
  • 36
    Vinters HV (1987) Cerebral amyloid angiopathy a critical review. Stroke 18:311324.
  • 37
    Vinters HV, Secor DL, Pardridge WM, Gray F (1990) Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy. Ann Neurol 28:3442.
  • 38
    Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE (1998) Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 153:725733.